lymphoma
BeiGene, CLL Society Partner to Promote Biomarker Testing in CLL, SLL
The partnership will support a campaign intended to increase the use of genomic testing to guide personalized therapy and improve outcomes.
City of Hope, Institute for Follicular Lymphoma Innovation Partner on $2M Research Program
The three-year effort will use DNA profiling, proteomics, and machine learning techniques to explore potential triggers of spontaneous remission.
Illumina, National Cancer Center Singapore Partner on Cancer Research Study
The partners will use Illumina's sequencing technologies to investigate the genomics of a rare cancer in Asian individuals.
Peripheral T-Cell Lymphoma Study Spells Out Molecular, Microenvironment Subtypes
Genomic and transcriptomic profiling on peripheral T-cell lymphoma pointed to molecular and microenvironment subtypes providing potential treatment and prognostic clues.
MRD Negativity After Lymphoma Therapy Predicted Outcomes Better Than Single PET-CT Scan in Study
Premium
Researchers concluded based on data shared at ASH that ctDNA testing can accurately predict who can forgo salvage therapy and may limit the number of tests.
Nov 19, 2020